Skip Navigation

This Article
Right arrow Print PDF (552K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (68)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Solomon, D. L.C.
Right arrow Articles by Land, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Solomon, D. L.C.
Right arrow Articles by Land, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1993, Vol. 21, No. 23 5372-5376
© 1993


MOLECULAR BIOLOGY

Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers

David L.C. Solomon, Bruno Amati and Hartmut Land*

Growth Control and Development Laboratory, Imperial Cancer Research Fund PO Box 123, Lincoln's Inn Fields, London WC2A 3PX, UK

*To Whom correspond should be addressed

Received August 27, 1993. Revised October 6, 1993. Accepted October 6, 1993.

The transcription factor c-Myc and its dimerisation partner Max are members of the basic/helix-loophelix/leucine-zipper (bHLH-Z) family and bind to the DNA core sequence CACGTG. Using a site-selection protocol, we determined the complete 12 base pair consensus binding sites of c-Myc/Max (RACCACGTGGTY) and Max/Max (RANCACGTGNTY) dimers. We find that the c-Myc/Max dimer fails to bind the core when it is flanked by a 5'T or a 3'A, while the Max/Max dimer readily binds such sequences. Furthermore we show that inappropriate flanking sequences preclude transactivation by c-Myc in vivo. In conclusion, Max/Max dimers are less discriminatory than c-Myc/Max and may regulate other genes in addition to c-Myc/Max targets.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
W. W. Hwang-Verslues and F. M. Sladek
Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha}1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter
Mol. Endocrinol., January 1, 2008; 22(1): 78 - 90.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. G. Pezzolesi, K. M. Zbuk, K. A. Waite, and C. Eng
Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome
Hum. Mol. Genet., May 1, 2007; 16(9): 1058 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. R. Lawlor, L. Soucek, L. Brown-Swigart, K. Shchors, C. U. Bialucha, and G. I. Evan
Reversible Kinetic Analysis of Myc Targets In vivo Provides Novel Insights into Myc-Mediated Tumorigenesis.
Cancer Res., May 1, 2006; 66(9): 4591 - 4601.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Carabana, E. Ortigoza, and M. S. Krangel
Regulation of the Murine D{delta}2 Promoter by Upstream Stimulatory Factor 1, Runx1, and c-Myb
J. Immunol., April 1, 2005; 174(7): 4144 - 4152.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Orian, B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W.M. Loo, S. M. Cowley, C. Yost, et al.
Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network
Genes & Dev., May 1, 2003; 17(9): 1101 - 1114.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
P. C. Fernandez, S. R. Frank, L. Wang, M. Schroeder, S. Liu, J. Greene, A. Cocito, and B. Amati
Genomic targets of the human c-Myc protein
Genes & Dev., May 1, 2003; 17(9): 1115 - 1129.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. James and R. N. Eisenman
Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions invivo
PNAS, August 6, 2002; 99(16): 10429 - 10434.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Berg, S. B. Cohen, J. Desharnais, C. Sonderegger, D. J. Maslyar, J. Goldberg, D. L. Boger, and P. K. Vogt
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts
PNAS, March 19, 2002; 99(6): 3830 - 3835.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Mundt, I. C. Nicholson, X. Zou, A. V. Popov, C. Ayling, and M. Bruggemann
Novel Control Motif Cluster in the IgH {{delta}}-{{gamma}}3 Interval Exhibits B Cell-Specific Enhancer Function in Early Development
J. Immunol., March 1, 2001; 166(5): 3315 - 3323.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. A. Baudino and J. L. Cleveland
The Max Network Gone Mad
Mol. Cell. Biol., February 1, 2001; 21(3): 691 - 702.
[Full Text]


Home page
Cancer Res.Home page
Y. Guo, R. B. Harris, D. Rosson, D. Boorman, and T. G. O’Brien
Functional Analysis of Human Ornithine Decarboxylase Alleles
Cancer Res., November 1, 2000; 60(22): 6314 - 6317.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. O. Mitchell, M. S. Ricci, T. Miyashita, D. T. Dicker, Z. Jin, J. C. Reed, and W. S. El-Deiry
Bax Is a Transcriptional Target and Mediator of c-Myc-induced Apoptosis
Cancer Res., November 1, 2000; 60(22): 6318 - 6325.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
P. J. Greasley, C. Bonnard, and B. Amati
Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis
Nucleic Acids Res., January 15, 2000; 28(2): 446 - 453.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. E. Boyd and P. J. Farnham
Identification of Target Genes of Oncogenic Transcription Factors
Experimental Biology and Medicine, October 2, 1999; 222(1): 9 - 28.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. Sjöblom-Hallén, W. Yang, A. Jansson, and L. Rymo
Silencing of the Epstein-Barr Virus Latent Membrane Protein 1 Gene by the Max-Mad1-mSin3A Modulator of Chromatin Structure
J. Virol., April 1, 1999; 73(4): 2983 - 2993.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
I. Aksan and C. R. Goding
Targeting the Microphthalmia Basic Helix-Loop-Helix-Leucine Zipper Transcription Factor to a Subset of E-Box Elements In Vitro and In Vivo
Mol. Cell. Biol., December 1, 1998; 18(12): 6930 - 6938.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. G. Perez, C. Gomez, E. Lopez-Bayghen, E. Tannich, and E. Orozco
Transcriptional Analysis of the EhPgp5 Promoter of Entamoeba histolytica Multidrug-resistant Mutant
J. Biol. Chem., March 27, 1998; 273(13): 7285 - 7292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sommer, K. Bousset, E. Kremmer, M. Austen, and B. Luscher
Identification and Characterization of Specific DNA-binding Complexes Containing Members of the Myc/Max/Mad Network of Transcriptional Regulators
J. Biol. Chem., March 20, 1998; 273(12): 6632 - 6642.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.